Initial Statement of Beneficial Ownership (3)
2021年5月8日 - 5:52AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Euclidean Capital LLC |
2. Date of Event Requiring Statement (MM/DD/YYYY)
4/28/2021
|
3. Issuer Name and Ticker or Trading Symbol
PMV Pharmaceuticals, Inc. [PMVP]
|
(Last)
(First)
(Middle)
160 FIFTH AVE, 9TH FL, |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director ___X___ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Street)
NEW YORK, NY 10010
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 693769 | I | See footnotes (1)(6) |
Common Stock | 2601637 | I | See footnotes (2)(6) |
Common Stock | 751409 | I | See footnotes (3)(6) |
Common Stock | 132601 | I | See footnotes (4)(6) |
Common Stock | 494407 | I | See footnotes (5)(6) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Marilyn Simons and James Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. |
(2) | The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. |
(3) | The shares are held of record by Greenland FP LLC, which is managed by Euclidean. |
(4) | The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. |
(5) | The shares are held of record by Symmetry Group Ltd ("Symmetry"). Mrs. Simons and Mr. Simons are on the board of directors of Symmetry's parent. |
(6) | Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Euclidean Capital LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY 10010 |
| X |
|
|
Greenland A LLC C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY 10010 |
| X |
|
|
Greenland FP LLC C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY 10010 |
| X |
|
|
Greenland NFP B Ltd. C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY 10010 |
| X |
|
|
Greenland NFP LLC C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY 10010 |
| X |
|
|
Symmetry Group Ltd. C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY 10010 |
| X |
|
|
Simons Marilyn C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY 10010 |
| X |
|
|
Chhabra Ashvin C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY 10010 |
| X |
|
|
SIMONS JAMES H C/O EUCLIDEAN CAPITAL LLC 160 FIFTH AVE, 9TH FL NEW YORK, NY 10010 |
| X |
|
|
Signatures
|
/s/ Joseph Cosmai - Euclidean Capital LLC, By: Joseph Cosmai, Manager | | 5/7/2021 |
**Signature of Reporting Person | Date |
/s/ Joseph Cosmai - Greenland A LLC, By: Joseph Cosmai, Manager of Euclidean Capital LLC, its Manager | | 5/7/2021 |
**Signature of Reporting Person | Date |
/s/ Joseph Cosmai - Greenland FP LLC, By: Joseph Cosmai, Manager of Euclidean Capital LLC, its Manager | | 5/7/2021 |
**Signature of Reporting Person | Date |
/s/ Joseph Cosmai - Greenland NFP B Ltd., By: Joseph Cosmai, Manager of Euclidean Capital LLC, its Manager | | 5/7/2021 |
**Signature of Reporting Person | Date |
/s/ Joseph Cosmai - Greenland NFP LLC, By: Joseph Cosmai, Manager of Euclidean Capital LLC, its Manager | | 5/7/2021 |
**Signature of Reporting Person | Date |
/s/ Jane Malone - Symmetry Group Ltd., By: Jane Malone, Officer of H.T.M. Services Ltd., its Director | | 5/7/2021 |
**Signature of Reporting Person | Date |
/s/ Iona Gordon - Symmetry Group Ltd., By: Iona Gordon, Officer of H.T.M. Services Ltd., its Director | | 5/7/2021 |
**Signature of Reporting Person | Date |
/s/ Marilyn Simons | | 5/7/2021 |
**Signature of Reporting Person | Date |
/s/ Ashvin Chhabra | | 5/7/2021 |
**Signature of Reporting Person | Date |
/s/ James Simons | | 5/7/2021 |
**Signature of Reporting Person | Date |
PMV Pharmaceuticals (NASDAQ:PMVP)
過去 株価チャート
から 6 2024 まで 7 2024
PMV Pharmaceuticals (NASDAQ:PMVP)
過去 株価チャート
から 7 2023 まで 7 2024